recent publications
-
academic article
- Rajagopal, V., Lincoff, A. M., Cohen, D. J., Gurm, H. S., Hu, T. F., Desmet, W. J., Kleiman, N. S., Bittl, J. A., Feit, F., Topol, E. J. Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention: An analysis from the randomized evaluation in pci linking angiomax to reduced clinical events (replace-2) trial American Heart Journal 2006 152:149-154 DOI:10.1016/j.ahj.2005.09.007 PMID:16824845
- Exaire, J. E., Butman, S. M., Ebrahimi, R., Kleiman, N. S., Harrington, R. A., Schweiger, M. J., Bittl, J. A., Wolski, K., Topol, E. J., Lincoff, A. M., Invest, Replace- Provisional glycoprotein iib/iiia blockade in a randomized investigation of bivalirudin versus heparin plus planned glycoprotein iib/iiia inhibition during percutaneous coronary intervention: Predictors and outcome in the randomized evaluation in percutaneous coronary intervention linking angiomax to reduced clinical events (replace)-2 trial American Heart Journal 2006 152:157-162 DOI:10.1016/j.ahj.2005.09.004 PMID:16824849
- Blankenship, J. C., Haldis, T., Feit, F., Hu, T. F., Kleiman, N. S., Topol, E. J., Lincoff, A. M., Investigators, Replace- Angiographic adverse events, creatine kinase-mb elevation, and ischemic end points complicating percutaneous coronary intervention (a replace-2 substudy) American Journal of Cardiology 2006 97:1591-1596 DOI:10.1016/j.amjcard.2005.12.050 PMID:16728220
- Mahaffey, K. W., Roe, M. T., Kilaru, R., French, J. K., Alexander, J. H., Berdan, L. G., Van De Werf, F., Simoons, M. L., Weaver, W. D., White, H. D., Lincoff, A. M., Kleiman, N. S., et al. Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromes American Journal of Cardiology 2005 95:1404-1408 DOI:10.1016/j.amjcard.2005.02.005 PMID:15950560
- Saw, J., Lincoff, A. M., DeSmet, W., Betriu, A., Rutsch, W., Wilcox, R. G., Kleiman, N. S., Wolski, K., Topol, E. J., Investigators, Replace- Lack of clopidogrel pretreatment effect on the relative efficacy of bivalirudin with provisional glycoprotein iib/iiia blockade compared to heparin with routine glycoprotein iib/iiia blockade - a replace-2 substudy Journal of the American College of Cardiology 2004 44:1194-1199 DOI:10.1016/j.jacc.2004.06.049 PMID:15364319
- Lincoff, A. M., Kleiman, N. S., Kereiakes, D. J., Feit, F., Bittl, J. A., Jackman, J. D., Sarembock, I. J., Cohen, D. J., Spriggs, D., Ebrahimi, R., Keren, G., Carr, J., et al. Long-term efficacy of bivalirudin and provisional glycoprotein iib/iiia blockade vs heparin and planned glycoprotein iib/iiia blockade during percutaneous coronary revascularization - replace-2 randomized trial JAMA-Journal of the American Medical Association 2004 292:696-703 DOI:10.1001/jama.292.6.696 PMID:15304466
- Rajagopal, V., Gurm, H. S., Bhatt, D. L., Lincoff, A. M., Tcheng, J. E., Kereiakes, D. J., Kleiman, N. S., Jia, G., Topol, E. J. Relation of an elevated white blood cell count after percutaneous coronary intervention to long-term mortality American Journal of Cardiology 2004 94:190-192 DOI:10.1016/j.amjcard.2004.03.060 PMID:15246898
- Gurm, H. S., Lincoff, A. M., Kleiman, N. S., Kereiakes, D. J., Tcheng, J. E., Aronow, H. D., Askari, A. T., Brennan, D. M., Topol, E. J. Double jeopardy of renal insufficiency and anemia in patients undergoing percutaneous coronary interventions American Journal of Cardiology 2004 94:30-34 DOI:10.1016/j.amjcard.2004.03.025 PMID:15219504
- Lincoff, A. M., Bittl, J. A., Kleiman, N. S., Sarembock, I. J., Jackman, J. D., Mehta, S., Tannenbaum, M. A., Niederman, A. L., Bachinsky, W. B., Tift-Mann, J., Parker, H. G., Kereiakes, D. J., et al. Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the randomized evaluation of pci linking angiomax to reduced clinical events replace -1 trial) American Journal of Cardiology 2004 93:1092-1096 DOI:10.1016/j.amjcard.2004.01.033 PMID:15110198
- Quinn, M. J., Aronow, H. D., Calif, R. M., Bhatt, D. L., Sapp, S., Kleiman, N. S., Harrington, R. A., Kong, D. F., Kandzari, D. E., Topol, E. J. Aspirin dose and six-month outcome after an acute coronary syndrome Journal of the American College of Cardiology 2004 43:972-978 DOI:10.1016/j.jacc.2003.09.059 PMID:15028352
- Gurm, H. S., Bhatt, D. L., Lincoff, A. M., Tcheng, J. E., Kereiakes, D. J., Kleiman, N. S., Jia, G., Topol, E. J. Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: Insights from the epic, epilog, and epistent trials Heart 2003 89:1200-1204 DOI:10.1136/heart.89.10.1200 PMID:12975419
- Lincoff, A. M., Bittl, J. A., Harrington, R. A., Feit, F., Kleiman, N. S., Jackman, J. D., Sarembock, I. J., Cohen, D. J., Spriggs, D., Ebrahimi, R., Keren, G., Carr, J., et al. Bivalirudin and provisional glycoprotein iib/iiia blockade compared with heparin and planned glycoprotein iib/iiia blockade during percutaneous coronary intervention - replace-2 randomized trial JAMA-Journal of the American Medical Association 2003 289:853-863 DOI:10.1001/jama.289.7.853 PMID:12588269
- Roffi, M., Chew, D. P., Mukherjee, D., Bhatt, D. L., White, J. A., Moliterno, D. J., Heeschen, C., Hamm, C. W., Robbins, M. A., Kleiman, N. S., Theroux, P., White, H. D., et al. Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes - gradient of benefit related to the revascularization strategy European Heart Journal 2002 23:1441-1448 DOI:10.1053/euhj.2002.3160 PMID:12208224
- Topol, E. J., Lincoff, A. M., Kereiakes, D. J., Kleiman, N. S., Cohen, E. A., Ferguson, J. J., Tcheng, J. E., Sapp, S., Califf, R. M. Multi-year follow-up of abciximab therapy in three randomized, placebo-controlled trials of percutaneous coronary revascularization American Journal of Medicine 2002 113:1-6 DOI:10.1016/s0002-9343(02)01145-2 PMID:12106616
- Lincoff, A. M., Kleiman, N. S., Kottke-Marchant, K., Maierson, E. S., Maresh, K., Wolski, K. E., Topol, E. J. Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: Results of the comparison of abciximab complications with hirulog for ischemic events trial (cachet) American Heart Journal 2002 143:847-853 DOI:10.1067/mhj.2002.122173 PMID:12040347
- Mazur, W., Kaluza, G. L., Sapp, S., Balog, C., Topol, E. J., Mark, D. B., Ellis, S. G., Kereiakes, D. J., Lincoff, A. M., Kleiman, N. S. Glycoprotein IIb-IIIa inhibition with abciximab and postprocedural risk assessment: lessons from the evaluation of platelet IIb/IIIa inhibitor for stenting trial and implication for ad hoc use of glycoprotein IIb-IIIa antagonists American Heart Journal 2002 143:594-601 DOI:10.1067/mhj.2002.121519 PMID:11923795
- Mahaffey, K. W., Roe, M. T., Dyke, C. K., Newby, L. K., Kleiman, N. S., Connolly, P., Berdan, L. G., Sparapani, R., Lee, K. L., Armstrong, P. W., Topol, E. J., Califf, R. M., et al. Misreporting of myocardial infarction end points: Results of adjudication by a central clinical events committee in the paragon-b trial American Heart Journal 2002 143:242-248 DOI:10.1067/mhj.2002.120145 PMID:11835026
- Rooner, E., Boersma, E., Akkerhuis, K. M., Harrington, R. A., Lincoff, A. M., Deckers, J. W., Karsch, K., Kleiman, N. S., Vahanian, A., Topol, E. J., Califf, R. M., Simoons, M. L. Patients with acute coronary syndromes without persistent st elevation undergoing percutaneous coronary intervention benefit most from early intervention with protection by a glycoprotein iib/iiia receptor blocker European Heart Journal 2002 23:239-246 DOI:10.1053/euhj.2001.2736 PMID:11792139
- Roffi, M., Chew, D. P., Mukherjee, D., Bhatt, D. L., White, J. A., Heeschen, C., Hamm, C. W., Moliterno, D. J., Califf, R. A., White, H. D., Kleiman, N. S., Theroux, P., et al. Platelet glycoprotein iib/iiia inhibitors reduce mortality in diabetic patients with non-st-segment-elevation acute coronary syndromes Circulation 2001 104:2767-2771 DOI:10.1161/hc4801.100029 PMID:11733392
- Aronow, H. D., Topol, E. J., Roe, M. T., Houghtaling, P. L., Wolski, K. E., Lincoff, A. M., Harrington, R. A., Califf, R. M., Ohman, E. M., Kleiman, N. S., Keltai, M., Wilcox, R. G., et al. Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: An observational study Lancet 2001 357:1063-1068 DOI:10.1016/s0140-6736(00)04257-4 PMID:11297956
- Mahaffey, K. W., Harrington, R. A., Akkerhuis, M., Kleiman, N. S., Berdan, L. G., Crenshaw, B. S., Tardiff, B. E., Granger, C. B., DeJong, I., Bhapkar, M., Widimsky, P., Corbalon, R., et al. Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: Review of the pursuit study Current Controlled Trials in Cardiovascular Medicine 2001 2:187-194 DOI:10.1186/cvm-2-4-187 PMID:11806794 PMCID:PMC57750
- Mahaffey, K. W., Harrington, R. A., Akkerhuis, M., Kleiman, N. S., Berdan, L. G., Crenshaw, B. S., Tardiff, B. E., Granger, C. B., DeJong, I., Bhapkar, M., Widimsky, P., Corbalon, R., et al. Systematic adjudication of myocardial infarction end-points in an international clinical trial Current Controlled Trials in Cardiovascular Medicine 2001 2:180-186 DOI:10.1186/cvm-2-4-180 PMID:11806793 PMCID:PMC57749
- Marso, S. P., Bhatt, D. L., Roe, M. T., Houghtaling, P. L., Labinaz, M., Kleiman, N. S., Dyke, C., Simmoons, M. L., Califf, R. M., Harrington, R. A., Topol, E. J., Investigators, Pursuit Enhanced efficacy of eptifibatide administration in patients with acute coronary syndrome requiring in-hospital coronary artery bypass grafting Circulation 2000 102:2952-2958 PMID:11113045
- Lincoff, A. M., Harrington, R. A., Califf, R. M., Hochman, J. S., Guerci, A. D., Ohman, E. M., Pepine, C. J., Kopecky, S. L., Kleiman, N. S., Pacchiana, C. M., Berdan, L. G., Kitt, M. M., et al. Management of patients with acute coronary syndromes in the united states by platelet glycoprotein iib/iiia inhibition - insights from the platelet glycoprotein iib/iiia in unstable angina: Receptor suppression using integrilin therapy (pursuit) trial Circulation 2000 102:1093-1100 PMID:10973836
- Cho, L., Topol, E. J., Balog, C., Foody, J. M., Booth, J. E., Cabot, C., Kleiman, N. S., Tcheng, J. E., Califf, R., Lincoff, M. A. Clinical benefit of glycoprotein iib/iiia blockade with abciximab is independent of gender - pooled analysis from epic, epilog and epistent trials Journal of the American College of Cardiology 2000 36:381-386 DOI:10.1016/s0735-1097(00)00746-4 PMID:10933346
- Batchelor, W. B., Granger, C. B., Kleiman, N. S., Phillips, H. R., Ellis, S. G., Betriu, A., Criger, D. A., Stebbins, A. L., Topol, E. J., Califf, R. M., Investigators, Gusto IIb A comparison of ionic versus nonionic contrast medium during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction (gusto iib) American Journal of Cardiology 2000 85:692-697 DOI:10.1016/s0002-9149(99)00842-5 PMID:12000041
- Kleiman, N. S., Lincoff, A. M., Flaker, G. C., Pieper, K. S., Wilcox, R. G., Berdan, L. G., Lorenz, T. J., Cokkinos, D. V., Simoons, M. L., Boersma, E., Topol, E. J., Califf, R. M., et al. Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes Circulation 2000 101:751-757 PMID:10683348
- Topol, C. E., Califf, R. M., Simes, R. J., Van de Werf, F., Diaz, R., Paolasso, E., Aylward, P. E., Keech, A., Klein, W., Piegas, L., Tomov, I., Armstrong, P. W., et al. Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: A randomised trial Lancet 2000 355:337-345 PMID:10665552
- Crenshaw, B. S., Granger, C. B., Birnbaum, Y., Pieper, K. S., Morris, D. C., Kleiman, N. S., Vahanian, A., Califf, R. M., Topol, E. J., Strepto, Gusto- I. Global Utilization Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction Circulation 2000 101:27-32 PMID:10618300
- Kleiman, N. S., Tracy, R. P., Talley, J. D., Sigmon, K., Joseph, D., Topol, E. J., Califf, R. M., Kitt, M., Ohman, E. M. Inhibition of platelet aggregation with a glycoprotein IIb-IIIa antagonist does not prevent thrombin generation in patients undergoing thrombolysis for acute myocardial infarction Journal of Thrombosis and Thrombolysis 2000 9:5-12 DOI:10.1023/a:1018650123272 PMID:10590183
- Braunwald, E., Califf, R. M., Cannon, C. P., Fox, K. A. A., Fuster, V., Gibler, W. B., Harrington, R. A., King, S. B., Kleiman, N. S., Theroux, P., Topol, E. J., Van de Werf, F., et al. Redefining medical treatment in the management of unstable angina American Journal of Medicine 2000 108:41-53 DOI:10.1016/s0002-9343(99)00416-7 PMID:11059440
- Marso, S. P., Lincoff, A. M., Ellis, S. G., Bhatt, D. L., Tanguay, J. F., Kleiman, N. S., Hammoud, T., Booth, J. E., Sapp, S. K., Topol, E. J., Investigators, Epistent Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus - results of the epistent (evaluation of platelet iib/iiia inhibitor for stenting trial) diabetic substudy Circulation 1999 100:2477-2484 PMID:10604884
- Miller, J. M., Smalling, R., Ohman, E. M., Bode, C., Betriu, A., Kleiman, N. S., Schildcrout, J. S., Bastos, E., Topol, E. J., Califf, R. M., GUSTO III Investigators Effectiveness of early coronary angioplasty and abciximab for failed thrombolysis (reteplase or alteplase) during acute myocardial infarction (results from the gusto-iii trial) American Journal of Cardiology 1999 84:779-784 DOI:10.1016/s0002-9149(99)00437-3 PMID:10513773
- Lincoff, A. M., Califf, R. M., Moliterno, D. J., Ellis, S. G., Ducas, J., Kramer, J. H., Kleiman, N. S., Cohen, E. A., Booth, J. E., Sapp, S. K., Cabot, C. F., Topol, E. J., et al. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators New England Journal of Medicine 1999 341:319-327 DOI:10.1056/nejm199907293410503 PMID:10423466
- McClure, M. W., Berkowitz, S. D., Sparapani, R., Tuttle, R., Kleiman, N. S., Berdan, L. G., Lincoff, A. M., Deckers, J., Diaz, R., Karsch, K. R., Gretler, D., Kitt, M., et al. Clinical significance of thrombocytopenia during a non-st-elevation acute coronary syndrome - the platelet glycoprotein iib iiia in unstable angina: Receptor suppression using integrilin therapy (pursuit) trial experience Circulation 1999 99:2892-2900 PMID:10359733
- Lincoff, A. M., Tcheng, J. E., Califf, R. M., Kereiakes, D. J., Kelly, T. A., Timmis, G. C., Kleiman, N. S., Booth, J. E., Balog, C., Cabot, C. F., Anderson, K. M., Weisman, H. F., et al. Sustained suppression of ischemic complications of coronary intervention by platelet gp iib/iiia blockade with abciximab - one-year outcome in the epilog trial Circulation 1999 99:1951-1958 PMID:10208997
- Kleiman, N. S., Granger, C. B., White, H. D., Armstrong, P., Ardissino, D., Van de Werf, F., Zoldeyhi, P., Thompson, T. D., Califf, R. M., Topol, E. J., Investigators, G. USTO-IIb Death and nonfatal reinfarction within the first 24 hours after presentation with an acute coronary syndrome: Experience from gusto-iib American Heart Journal 1999 137:12-23 DOI:10.1016/s0002-8703(99)70455-2 PMID:9878932
- Ellis, S. G., Lincoff, A. M., Miller, D., Tcheng, J. E., Kleiman, N. S., Kereiakes, D., Califf, R., Topol, E. J., Investigators, Epilog, Investigators, Epic Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology Journal of the American College of Cardiology 1998 32:1619-1623 DOI:10.1016/s0735-1097(98)00403-3 PMID:9822087
- Kereiakes, D. J., Kleiman, N. S., Ferguson, J. J., Masud, Z., Broderick, T. M., Abbottsmith, C. W., Runyon, J. P., Anderson, L. C., Anders, R. J., Dreiling, R. J., Hantsbarger, G. L., Bryzinski, B., et al. Pharmacodynamic efficacy, clinical safety, and outcomes after prolonged platelet glycoprotein iib/iiia receptor blockade with oral xemilofiban - results of a multicenter, placebo-controlled, randomized trial Circulation 1998 98:1268-1278 PMID:9751674
- Topol, E. J., Lincoff, A. M., Califf, R. M., Tcheng, J. E., Kleiman, N. S., Adelman, A. G., Burton, J. R., Talley, J. D., Ivanhoe, R. J., Ducas, C., Cheung, P. K., Schick, U., et al. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade Lancet 1998 352:87-92 DOI:10.1016/s0140-6736(98)85010-1 PMID:9672272
- Ghaffari, S., Kereiakes, D. J., Lincoff, A. M., Kelly, T. A., Timmis, G. C., Kleiman, N. S., Ferguson, J. J., Miller, D. P., Califf, R. A., Topol, E. J., Investigators, Epilog Platelet glycoprotein iib/iia receptor blockade with abciximab reduces ischemic complications in patients undergoing directional coronary atherectomy American Journal of Cardiology 1998 82:7-12 DOI:10.1016/s0002-9149(98)00238-0 PMID:9671000
- Kleiman, N. S., Lincoff, A. M., Kereiakes, D. J., Miller, D. P., Aguirre, F. V., Anderson, K. M., Weisman, H. F., Califf, R. M., Topol, E. J., Investigators, Epilog Diabetes mellitus, glycoprotein iib/iiia blockade, and heparin - evidence for a complex interaction in a multicenter trial Circulation 1998 97:1912-1920 PMID:9609084
- Brieger, D. B., Mak, K. H., White, H. D., Kleiman, N. S., Miller, D. P., Vahanian, A., Ross, A. M., Califf, R. M., Topol, E. J., Investigators, Gusto- I. Benefit of early sustained reperfusion in patients with prior myocardial infarction (the gusto-i trial) American Journal of Cardiology 1998 81:282-287 DOI:10.1016/s0002-9149(97)00909-0 PMID:9468068
- Califf, R. M., Abdelmeguid, A. E., Kuntz, R. E., Popma, J. J., Davidson, C. J., Cohen, E. A., Kleiman, N. S., Mahaffey, K. W., Topol, E. J., Pepine, C. J., Lipicky, R. J., Granger, C. B., et al. Myonecrosis after revascularization procedures Journal of the American College of Cardiology 1998 31:241-251 DOI:10.1016/s0735-1097(97)00506-8 PMID:9462562
- Khan, M. M., Ellis, S. G., Aguirre, F. V., Weisman, H. F., Wildermann, N. M., Califf, R. M., Topol, E. J., Kleiman, N. S., Invest, Epic Does intracoronary thrombus influence the outcome of high risk percutaneous transluminal coronary angioplasty? Clinical and angiographic outcomes in a large multicenter trial Journal of the American College of Cardiology 1998 31:31-36 DOI:10.1016/s0735-1097(97)00423-3 PMID:9426014
- Topol, E. J., Ferguson, J. J., Weisman, H. F., Tcheng, J. E., Ellis, S. G., Kleiman, N. S., Ivanhoe, R. J., Wang, A. L., Miller, D. P., Anderson, K. M., Califf, R. M. Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta(3) blockade with percutaneous coronary intervention JAMA-Journal of the American Medical Association 1997 278:479-484 DOI:10.1001/jama.278.6.479 PMID:9256222
- Lincoff, A. M., Califf, R. M., Anderson, K. M., Weisman, H. F., Aguirre, F. V., Kleiman, N. S., Harrington, R. A., Topol, E. J. Evidence for prevention of death and myocardial infarction with platelet membrane glycoprotein iib/iiia receptor blockade by abciximab (c7e3 fab) among patients with unstable angina undergoing percutaneous coronary revascularization Journal of the American College of Cardiology 1997 30:149-156 PMID:9207636
- Topol, E. J., Califf, R. M., Lincoff, A. M., Tcheng, J. E., Cabot, C. F., Weisman, H. F., Kereiakes, D., Lausten, D., Runyon, J. P., Howard, W., Kelly, T., Muncy, D., et al. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization New England Journal of Medicine 1997 336:1689-1696 PMID:9182212
- Tcheng, J. E., Lincoff, A. M., Sigmon, K. N., Lee, K. L., Kitt, M. M., Califf, R. M., Topol, E. J., Juran, N., Worley, S., Tuzi, J., Hollywood, L., Kleiman, N. S., et al. Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT II Lancet 1997 349:1422-1428 PMID:9164315
- Ohman, E. M., Kleiman, N. S., Gacioch, G., Worley, S. J., Navetta, F. I., Talley, J. D., Anderson, H. V., Ellis, S. G., Cohen, M. D., Spriggs, D., Miller, M., Kereiakes, D., et al. Combined accelerated tissue-plasminogen activator and platelet glycoprotein iib/iiia integrin receptor blockade with integrin in acute myocardial infarction - results of a randomized, placebo-controlled, dose-ranging trial Circulation 1997 95:846-854 PMID:9054741
- Lincoff, A. M., Tcheng, J. E., Califf, R. M., Bass, T., Popma, J. J., Teirstein, P. S., Kleiman, N. S., Hattel, L. J., Anderson, H. V., Ferguson, J. J., Cabot, C. F., Anderson, K. M., et al. Standard versus low-dose weight-adjusted heparin in patients treated with the platelet glycoprotein iib/iiia receptor antibody fragment abciximab (c7e3 fab) during percutaneous coronary revascularization American Journal of Cardiology 1997 79:286-291 PMID:9036746
- Labinaz, M., Sketch, M. H., Stebbins, A. L., DeFranco, A. C., Holmes, D. R., Kleiman, N. S., Betriu, A., Rutsch, W. R., Vahanian, A., Topol, E. J., Califf, R. M. Thrombolytic therapy for patients with prior percutaneous transluminal coronary angioplasty and subsequent acute myocardial infarction American Journal of Cardiology 1996 78:1338-1344 DOI:10.1016/s0002-9149(96)00654-6 PMID:8970403
- Ohman, E. M., Armstrong, P. W., Christenson, R. H., Granger, C. B., Katus, H. A., Hamm, C. W., Ohanesian, M. A., Wagner, G. S., Kleiman, N. S., Harrell, F. E., Califf, R. M., Topol, E. J. Cardiac troponin t levels for risk stratification in acute myocardial ischemia New England Journal of Medicine 1996 335:1333-1341 DOI:10.1056/nejm199610313351801 PMID:8857016
- White, H. D., Barbash, G. I., Califf, R. M., Simes, R. J., Granger, C. B., Weaver, W. D., Kleiman, N. S., Aylward, P. E., Gore, J. M., Vahanian, A., Lee, K. L., Ross, A. M., et al. Age and outcome with contemporary thrombolytic therapy - results from the gusto-i trial Circulation 1996 94:1826-1833 PMID:8873656
- Aguirre, F. V., Topol, E. J., Anderson, K. M., Kleiman, N. S., Weisman, H. E., FitzPatrick, S. E., Califf, R. M. Clinical benefit within patient subgroups receiving c7e3 fab (abciximab) during percutaneous coronary revascularization: Subgroup analysis from the epic trial Journal of Invasive Cardiology 1996 8:B21-B29
- Harrington, R. A., Kleiman, N. S., Kottkemarchant, K., Lincoff, A. M., Tcheng, J. E., Sigmon, K. N., Joseph, D., Rios, G., Trainor, K., Rose, D., Greenberg, C. S., Kitt, M. M., et al. Immediate and reversible platelet inhibition after intravenous administration of a peptide glycoprotein iib/iiia inhibitor during percutaneous coronary intervention American Journal of Cardiology 1995 76:1222-1227 DOI:10.1016/s0002-9149(99)80345-2 PMID:7503000
- Holmes, D. R., Bates, E. R., Kleiman, N. S., Sadowski, Z., Horgan, J. H. S., Morris, D. C., Califf, R. M., Berger, P. B., Topol, E. J. Contemporary reperfusion therapy for cardiogenic-shock - the gusto-i trial experience Journal of the American College of Cardiology 1995 26:668-674 DOI:10.1016/0735-1097(95)00215-p PMID:7642857
- Tcheng, J. E., Harrington, R. A., Kottkemarchant, K., Kleiman, N. S., Ellis, S. G., Kereiakes, D. J., Mick, M. J., Navetta, F. I., Smith, J. E., Worley, S. J., Miller, J. A., Joseph, D. M., et al. Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein iib/iiia blocker integrelin in elective coronary intervention Circulation 1995 91:2151-2157 PMID:7697843
- Kleiman, N. S., White, H. D., Ohman, E. M., Ross, A. M., Woodlief, L. H., Califf, R. M., Holmes, D. R., Bates, E., Pfisterer, M., Vahanian, A., Topol, E. J. Mortality within 24 hours of thrombolysis for myocardial-infarction - the importance of early reperfusion Circulation 1994 90:2658-2665 PMID:7994805
- Tcheng, J. E., Ellis, S. G., George, B. S., Kereiakes, D. J., Kleiman, N. S., Talley, J. D., Wang, A. L., Weisman, H. F., Califf, R. M., Topol, E. J. Pharmacodynamics of chimeric glycoprotein iib/iiia integrin antiplatelet antibody fab 7e3 in high-risk coronary angioplasty Circulation 1994 90:1757-1764 PMID:7923659
- Topol, E. J., Fuster, V., Harrington, R. A., Califf, R. M., Kleiman, N. S., Kereiakes, D. J., Cohen, M., Chapekis, A., Gold, H. K., Tannenbaum, M. A., Rao, A. K., Debowey, D., et al. Recombinant hirudin for unstable angina-pectoris - a multicenter, randomized angiographic trial Circulation 1994 89:1557-1566 PMID:8149521
- Williams, D. O., Topol, E. J., Califf, R. M., Roberts, R., Mancini, G. B. J., Joelson, J. M., Ellis, S. G., Kleiman, N. S. Intravenous recombinant tissue-type plasminogen-activator in patients with unstable angina-pectoris - results of a placebo-controlled, randomized trial Circulation 1990 82:376-383 PMID:2115407